Infleqtion (INFQ) Q4 2025 Financial Results Summary
· Stocks · QuoteReporter
Infleqtion (INFQ) Q1 2026 Financial Results Summary
On April 1, 2026, Infleqtion (NYSE: INFQ), a leader in quantum computing and sensing technology, released its financial results for the year ending December 31, 2025, alongside its outlook for 2026.
Financial Highlights for Full Year Ending December 31, 2025
- Revenue: $32.5 million.
- Growth: Not provided (this is the first reported figure).
- Loss from Operations: $35.3 million.
- Improvement: Decreased from a loss of $53.0 million in 2024.
- Non-GAAP Operating Loss: $28.1 million.
- Improvement: Reduced from $35.7 million in 2024.
- Stock-Based Compensation: $3.1 million, which was down from $3.7 million in 2024.
- Acquisition and Integration Costs: $4.1 million, incurred during the year, recorded for the first time.
- Net Loss: $31.8 million.
- Improvement: Decreased from $53.8 million in 2024.
- Non-GAAP Net Loss: $24.6 million.
- Improvement: Reduced from $38.4 million in 2024.
Business Highlights
- April 2026: Infleqtion announced its first quantum-enabled precision timing solution in collaboration with Safran Electronics & Defense, demonstrating advancements in quantum technology for defense and telecommunications.
- March 2026: The company delivered the UK’s only operational 100-physical qubit quantum computing system at the National Quantum Computing Centre, marking a significant achievement in national quantum objectives.
- March 2026: The company secured an additional award from ARPA-E, receiving $3.9 million to advance its chemistry and materials science applications.
- February 2026: Infleqtion became a collaborator on NASA’s Quantum Gravity Gradiometer Pathfinder mission, obtaining over $20 million in contracted funding to date.
- CEO Statement: Matthew Kinsella emphasized the growing demand for quantum technologies in critical applications as a reflection of the company’s strengthened position in the market.
Future Outlook
2026 Revenue Guidance: Infleqtion is projecting revenue of $40 million for 2026, indicating a substantial growth of 23% compared to the 2025 revenue figure of $32.5 million.
Dividends and Share Repurchases
Infleqtion did not declare any quarterly dividends or share repurchases in the report.
Conference Call Information
A conference call is scheduled for April 8, 2026, at 4:30 p.m. Eastern Time, which will be available via a live webcast and subsequent playback options.
Conclusion
Infleqtion is positioning itself for growth in the quantum technology sector, with significant improvements in its financial metrics for the year ending December 31, 2025, compared to the previous year. The company continues to bolster its operations and product offerings, aligning with increasing market demand for advanced quantum solutions.
Condensed Consolidated Statements of Income (in thousands)
Note: All amounts are in thousands.
| For the period ended December 31, | 2025 | 2024 |
|---|---|---|
| Revenue | $32,500 | $XX,XXX |
| Loss from operations | $(35,286) | $(53,008) |
| Add: | ||
| Stock-based compensation | $3,056 | $3,741 |
| Acquisition and integration costs | $4,114 | $0 |
| Impairment of assets and goodwill | $0 | $13,539 |
| Non-GAAP operating loss | $(28,116) | $(35,728) |
| Net loss | $(31,795) | $(53,764) |
| Add: | ||
| Stock-based compensation | $3,056 | $3,741 |
| Acquisition and integration costs | $4,114 | $0 |
| Change in fair value of contingent consideration | $0 | $380 |
| Change in fair value of SAFE liabilities | $0 | $(2,271) |
| Impairment of assets and goodwill | $0 | $13,539 |
| Non-GAAP net loss | $(24,625) | $(38,375) |
Condensed Consolidated Balance Sheets (in thousands)
Note: All amounts are in thousands.
| As of December 31, | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current assets | $XX,XXX | $XX,XXX |
| Long-term financing receivables | $XX,XXX | $XX,XXX |
| Property and equipment | $XX,XXX | $XX,XXX |
| Other assets | $XX,XXX | $XX,XXX |
| Total Assets | $XX,XXX | $XX,XXX |
| Liabilities | ||
| Current liabilities | $XX,XXX | $XX,XXX |
| Long-term liabilities | $XX,XXX | $XX,XXX |
| Total Liabilities | $XX,XXX | $XX,XXX |
| Shareholders' Equity | ||
| Common stock and additional paid-in capital | $XX,XXX | $XX,XXX |
| Other equity | $XX,XXX | $XX,XXX |
| Total Shareholders' Equity | $XX,XXX | $XX,XXX |
| Total Liabilities and Shareholders' Equity | $XX,XXX | $XX,XXX |
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.